| Kidney rules exempt oral meds from Amgen, Genzyme - FiercePharma |
|
|
FiercePharmaThere's a silver lining in new Medicare rules for dialysis patients for Amgen (NASDAQ: AMGN), which stands to lose a big chunk of sales of its IV anemia ... read more |